Bright Angel Therapeutics
PrivateLast Round
Seed
Dec 3, 2019
Company Overview
Bright Angel Therapeutics is a biotechnology company that develops novel antifungal drugs to treat drug-resistant and life-threatening invasive fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bright Angel Therapeutics Comparables
Compare Bright Angel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rostra Therapeutics | 82% | |
| Brigid Bio Ltd | 78% | |
| Elion Therapeutics | 76% |
Bright Angel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2019 | ||||
| Seed | Dec 21, 2017 |
Bright Angel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viva BioInnovator | Seed |
| Lumira Ventures | Seed |
| TIAP | Seed |
| adMare BioInnovations | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors grew 70% MoM.
- Oct 30, 2024
Monthly visitors increased 139% MoM.
Bright Angel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bright Angel Therapeutics's valuation, stock price, and market status.
Is Bright Angel Therapeutics a public or private company?
Bright Angel Therapeutics is a private company.
What is the current stock price of Bright Angel Therapeutics?
Bright Angel Therapeutics is a private company, so its shares have no public market price. Caplight tracks Bright Angel Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bright Angel Therapeutics worth (valuation)?
Valuation information for Bright Angel Therapeutics is not publicly available.
Can I buy Bright Angel Therapeutics stock?
Bright Angel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bright Angel Therapeutics's last funding round?
Bright Angel Therapeutics's most recent funding round was Seed on December 3, 2019.
Who are the main investors in Bright Angel Therapeutics?
Key investors in Bright Angel Therapeutics include Viva BioInnovator, Lumira Ventures, TIAP, adMare BioInnovations.
Will Bright Angel Therapeutics IPO soon?
No public IPO plans have been announced for Bright Angel Therapeutics.
How can I track Bright Angel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Bright Angel Therapeutics's shares on secondary markets.